First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants
Author:
Affiliation:
1. Research and Development, Bristol Myers Squibb, Princeton, NJ, USA
Funder
Bristol Myers Squibb
Publisher
Informa UK Limited
Subject
Hematology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/09537104.2023.2222846
Reference20 articles.
1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
2. Cardiovascular diseases (CVDs): World Health Organization (WHO). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
3. Recurrent ischemic stroke: strategies for prevention;Oza R;Am Fam Physician,2017
4. Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?
5. Novel Antithrombotic Drugs on the Horizon
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets;Research and Practice in Thrombosis and Haemostasis;2024-08
2. Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions;Biomedicines;2024-07-26
3. Protease activated receptor-4: ready to be part of the antithrombosis spectrum;Current Opinion in Hematology;2024-05-30
4. Direct neuronal protection by the protease‐activated receptor PAR4 antagonist ML354 after experimental stroke in mice;British Journal of Pharmacology;2024-05-17
5. The thrombin receptor PAR4 supports visceral adipose tissue inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3